{
    "eid": "2-s2.0-85154572805",
    "title": "Immunoinflammatory and oxidative alterations in subjects with schizophrenia under clozapine: A meta-analysis",
    "cover-date": "2023-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Psychiatry and Mental Health",
            "@code": "2738",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Biological Psychiatry",
            "@code": "2803",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Clozapine",
        "Compensatory Immune Response System",
        "Cytokines",
        "Inflammatory Response System",
        "Meta-analysis",
        "Psychotic disorders"
    ],
    "authors": [
        "Paulo Levi Bezerra Martins",
        "Ian Ara\u00fajo Moura",
        "Gabrielle Mendes",
        "Vit\u00f3ria Cristina Almeida Flexa Ribeiro",
        "Andr\u00e9 Arnaud",
        "Clarissa S. Gama",
        "Michael Maes",
        "Danielle S. Macedo",
        "Joel Porfirio Pinto"
    ],
    "citedby-count": 0,
    "ref-count": 52,
    "ref-list": [
        "Serum TNF-\u03b1, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine",
        "Evidence-based guidelines for the pharmacological treatment of schizophrenia: updated recommendations from the British Association for Psychopharmacology",
        "Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study",
        "Prevalence and medical costs of chronic diseases among adult medicaid beneficiaries",
        "The Economic Burden of Schizophrenia in the United States in 2013",
        "Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care",
        "Immune and neuroendocrine trait and state markers in psychotic illness: decreased kynurenines marking psychotic exacerbations",
        "Potent inhibition of both human interferon-gamma production and biologic activity by the Clara cell protein CC16",
        "Cytokines as endogenous pyrogens",
        "Serum cytokine profile in Schizophrenic patients",
        "Serum IL-1\u03b2, sIL-2R, IL-6, IL-8 and TNF-\u03b1 in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment",
        "Serum IL-1\u03b2, sIL-2R, IL-6, IL-8 and TNF-\u03b1 in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment",
        "A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression",
        "Decreased production of reactive oxygen species by blood monocytes caused by clozapine correlates with EEG slowing in schizophrenic patients",
        "GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables",
        "Toxic rise of clozapine plasma concentrations in relation to inflammation",
        "Mortality among patients with schizophrenia and reduced psychiatric hospital care",
        "Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone",
        "Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients",
        "Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis",
        "Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology",
        "Role of cytokine changes in clozapine-induced fever: a cohort prospective study",
        "Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017",
        "Panss, mental condition and inflammatory state of risperidone on schizophrenia",
        "The societal cost of schizophrenia: a systematic review",
        "Is there an association between the effects of clozapine on the production of reactive oxygen metabolites by blood monocytes and clinical outcome in neuroleptic-resistant schizophrenia?",
        "Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine",
        "Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever",
        "Association of secondary preventive cardiovascular treatment after myocardial infarction with mortality among patients with schizophrenia",
        "Precision psychiatry: the complexity of personalizing antipsychotic dosing",
        "Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor",
        "In vivo immunomodulatory effects of clozapine in schizophrenia",
        "Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine",
        "First episode psychosis and schizophrenia are systemic neuro-immune disorders triggered by a biotic stimulus in individuals with reduced immune regulation and neuroprotection",
        "Prevention of suicide by clozapine in mental disorders: systematic review",
        "Interactions among brain-derived neurotrophic factor and neuroimmune pathways are key components of the major psychiatric disorders",
        "Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients",
        "Altering the course of schizophrenia: progress and perspectives",
        "Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects",
        "Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses",
        "High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance",
        "Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis",
        "Increased mortality among people with schizophrenia and other non-affective psychotic disorders in the community: a systematic review and meta-analysis",
        "Pro-inflammatory cytokine levels are raised in female schizophrenia patients treated with clozapine",
        "The role of aberrations in the immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in different phenotypes of schizophrenia: the IRS-CIRS theory of schizophrenia",
        "Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication",
        "ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions",
        "RoB 2: a revised tool for assessing risk of bias in randomised trials",
        "Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist",
        "Systematic review and collaborative recalculation of 133,693 incident cases of schizophrenia",
        "Cytokine production in the central nervous system",
        "Elevated interleukin-18 serum levels in chronic schizophrenia: association with psychopathology"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Fortaleza",
            "@id": "60020457",
            "affilname": "Universidade Federal do Cear\u00e1",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020457",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Fortaleza",
            "@id": "60015440",
            "affilname": "Universidade de Fortaleza",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015440",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Porto Alegre",
            "@id": "60014120",
            "affilname": "Hospital de Clinicas de Porto Alegre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014120",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Porto Alegre",
            "@id": "60006726",
            "affilname": "Universidade Federal do Rio Grande do Sul",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006726",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Ribeirao Preto",
            "@id": "107163515",
            "affilname": "CNPq",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/107163515",
            "affiliation-country": "Brazil"
        }
    ],
    "funding": [
        "Brazilian National Council for Scientific and Technological Development CNPq",
        "CAPES",
        "CNPq",
        "FUNCAP"
    ]
}